Top Markets
#1 EXOD EXOD +22.08%
#2 XPIN Network XPIN Network +19.36%
#3 Geodnet Geodnet +17.32%
#4 BOOK OF MEME BOOK OF MEME +17.24%
#5 Derive Derive +15.68%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +15.67%
#7 SSV Network SSV Network +15.42%
#8 Bitcoin Cash Bitcoin Cash +15.34%
#9 The Black Bull The Black Bull +14.65%
#10 Mubarak Mubarak +14.45%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Rangering i aksjer #25246
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Aksjekurs
$23.57
Sist synkronisert: 2026-08-20
Markedsverdi
$51.76M
Endring (1 dag)
-0.08%
Endring (1 år)
289.59%
Land
US
Handel Apollomics, Inc. (APLM)

Kategori

Healthcare
P/B-forhold for Apollomics, Inc. (APLM)
P/B-forhold per 2026 TTM: 0
Ifølge Apollomics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Apollomics, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US